Real-world evidence costs of allergic rhinitis and allergy immunotherapy in the commercially insured United States population

References

• Khan DA. Allergic rhinitis and asthma: epidemiology and common pathophysiology. Allergy Asthma Proc. 2014 Sep-Oct;35:357–361.
   PubMed Web of Science ®Google Scholar
• Mims JW. Epidemiology of allergic rhinitis. Int Forum Allergy Rhinol. 2014; 4 Suppl(2) :S18–S20.
   PubMed Web of Science ®Google Scholar
• World Health Organization. White Book on Allergy 2011–2012 Executive Summary Milwaukee, WI2012 [December, 12, 2019. Available from: https://www.worldallergy.org/UserFiles/file/WAO-White-Book-on-Allergy_web.pdf.
   Google Scholar
• Blaiss MS. Allergic rhinitis: direct and indirect costs. Allergy Asthma Proc. 2010; 31:375–380.
   PubMed Web of Science ®Google Scholar
• Allen-Ramey F, Mao J, Blauer-Peterson C, et al. Healthcare costs for allergic rhinitis patients on allergy immunotherapy: a retrospective observational study. Curr Med Res Opin. 2017; 33:2039–2047.
   PubMed Web of Science ®Google Scholar
• Law AW, Reed SD, Sundy JS, et al. Direct costs of allergic rhinitis in the United States: estimates from the 1996 Medical Expenditure Panel Survey. J Allergy Clin Immunol. 2003; 111:296–300.
   PubMed Web of Science ®Google Scholar
• Meltzer EO, Bukstein DA. The economic impact of allergic rhinitis and current guidelines for treatment. Ann Allergy Asthma Immunol. 2011;106:S12–S6.
   PubMed Web of Science ®Google Scholar
• Mudarri DH. Valuing the economic costs of allergic rhinitis, acute bronchitis, and asthma from exposure to indoor dampness and mold in the US. J Environ Public Health. 2016;2016:2386596.
   PubMed Web of Science ®Google Scholar
• Reed SD, Lee TA, McCrory DC. The economic burden of allergic rhinitis: a critical evaluation of the literature. Pharmacoeconomics. 2004;22:345–361.
   PubMed Web of Science ®Google Scholar
• Dalal AA, Stanford R, Henry H, et al. Economic burden of rhinitis in managed care: a retrospective claims data analysis. Ann Allergy Asthma Immunol. 2008;101:23–29.
   PubMed Web of Science ®Google Scholar
• Shaaban R, Zureik M, Soussan D, et al. Rhinitis and onset of asthma: a longitudinal population-based study. Lancet. 2008;372:1049–1057.
   PubMed Web of Science ®Google Scholar
• Guerra S, Sherrill DL, Martinez FD, et al. Rhinitis as an independent risk factor for adult-onset asthma. J Allergy Clin Immunol. 2002;109:419–425.
   PubMed Web of Science ®Google Scholar
• Hopper JL, Bui QM, Erbas B, et al. Does eczema in infancy cause hay fever, asthma, or both in childhood? Insights from a novel regression model of sibling data. J Allergy Clin Immunol. 2012; 130:1117–1122.e1.
   PubMed Web of Science ®Google Scholar
• Bielory L. Allergic conjunctivitis and the impact of allergic rhinitis. Curr Allergy Asthma Rep. 2010;10:122–134.
   PubMed Web of Science ®Google Scholar
• Hadley JA, Derebery MJ, Marple BF. Comorbidities and allergic rhinitis: not just a runny nose. J Fam Pract. 2012;61:S11–S15.
   PubMedGoogle Scholar
• Celakovska J, Bukac J. Food allergy in patients suffering from atopic dermatitis – association with concomitant allergic diseases. Food Agr Immunol. 2015;26:325–339.
   Web of Science ®Google Scholar
• Čelakovská J, Ettlerová K, Ettler K, et al. Food allergy, asthma bronchiale, and rhinitis in atopic dermatitis patients with total immunoglobulin E under and above 200 IU/ml. Food Agricult Immunol. 2015;26:671–681.
   Web of Science ®Google Scholar
• Settipane RA, Kreindler JL, Chung Y, et al. Evaluating direct costs and productivity losses of patients with asthma receiving GINA 4/5 therapy in the United States. Ann Allergy Asthma Immunol. 2019; 123:564–572 e3.
   PubMed Web of Science ®Google Scholar
• Adamson AS. The economics burden of atopic dermatitis. Adv Exp Med Biol. 2017;1027:79–92.
   PubMed Web of Science ®Google Scholar
• May JR, Dolen WK. Management of allergic rhinitis: a review for the community pharmacist. Clin Ther. 2017;39:2410–2419.
   PubMed Web of Science ®Google Scholar
• Burks AW, Calderon MA, Casale T, et al. Update on allergy immunotherapy: American Academy of Allergy, Asthma & Immunology/European Academy of Allergy and Clinical Immunology/PRACTALL consensus report. J Allergy Clin Immunol. 2013;131:1288–1296 e3.
   PubMed Web of Science ®Google Scholar
• Cox LS, Murphey A, Hankin C. The cost-effectiveness of allergen immunotherapy compared with pharmacotherapy for treatment of allergic rhinitis and asthma. Immunol Allergy Clin North Am. 2020;40:69–85.
   PubMed Web of Science ®Google Scholar
• Tinkelman D, Smith F, Cole WQ, 3rd, et al. Compliance with an allergen immunotherapy regime. Ann Allergy Asthma Immunol. 1995;74:241–246.
   PubMed Web of Science ®Google Scholar
• Silva D, Pereira A, Santos N, et al. Costs of treatment affect compliance to specific subcutaneous immunotherapy. Eur Ann Allergy Clin Immunol. 2014;46:87–94.
   PubMedGoogle Scholar
• Hsu NM, Reisacher WR. A comparison of attrition rates in patients undergoing sublingual immunotherapy vs subcutaneous immunotherapy. Int Forum Allergy Rhinol. 2012;2:280–284.
   PubMed Web of Science ®Google Scholar
• Cohn JR, Pizzi A. Determinants of patient compliance with allergen immunotherapy. J Allergy Clin Immunol. 1993;91:734–737.
   PubMed Web of Science ®Google Scholar
• American Medical Association. CPT 2019 Professional Edition. 5th revised ed. Chicago (IL): American Medical Association; 2019.
   Google Scholar
• Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992;45:613–619.
   PubMed Web of Science ®Google Scholar
• United States Bureau of Labor Statistics. Consumer Price Index for All Urban Consumers: Medical care in U.S. city average, all customers, not seasonally adjusted Washington; 2019 [2019 December 19]. Available from: https://www.bls.gov/cpi/
   Google Scholar
• Chapel JM, Ritchey MD, Zhang D, et al. Prevalence and medical costs of chronic diseases among adult medicaid beneficiaries. Am J Prev Med. 2017;53:S143–S154.
   PubMed Web of Science ®Google Scholar
• Yu H, MacIsaac D, Wong JJ, et al. Market share and costs of biologic therapies for inflammatory bowel disease in the USA. Aliment Pharmacol Ther. 2018;47:364–370.
   PubMed Web of Science ®Google Scholar
• Gillespie CW, Morin PE, Tucker JM, et al. Medication adherence, health care utilization, and spending among privately insured adults with chronic conditions in the United States, 2010-2016. Am J Med. 2020;133:690–704 e19.
   PubMed Web of Science ®Google Scholar
• Mojtabai R, Olfson M. Medication costs, adherence, and health outcomes among medicare beneficiaries. Health Aff (Millwood)). 2003;22:220–229.
   PubMed Web of Science ®Google Scholar
• ALK-Abelló A/S. Grastek (timothy grass pollen allergen extract) [package insert]. U.S. Food and Drug Administration 2014. Available from: https://www.fda.gov/media/88510/download
   Google Scholar
• Jin J, Sklar GE, Min Sen Oh V, et al. Factors affecting therapeutic compliance: a review from the patient's perspective. Ther Clin Risk Manag. 2008;4:269–286.
   PubMedGoogle Scholar
• Vogelberg C, Bruggenjurgen B, Richter H, et al. Real-world adherence and evidence of subcutaneous and sublingual immunotherapy in grass and tree pollen-induced allergic rhinitis and asthma. Patient Prefer Adherence. 2020;14:817–827.
   PubMed Web of Science ®Google Scholar
• Borg M, Lokke A, Hilberg O. Compliance in subcutaneous and sublingual allergen immunotherapy: a nationwide study. Respir Med. 2020;170:106039.
   PubMed Web of Science ®Google Scholar
• Meltzer EO, Gross GN, Katial R, et al. Allergic rhinitis substantially impacts patient quality of life: findings from the Nasal Allergy Survey Assessing Limitations. J Fam Pract. 2012;61:S5–S10.
   PubMedGoogle Scholar
• Ozdoganoglu T, Songu M, Inancli HM. Quality of life in allergic rhinitis. Ther Adv Respir Dis. 2012; 6:25–39.
   PubMed Web of Science ®Google Scholar
• Ciprandi G, Klersy C, Cirillo I, et al. Quality of life in allergic rhinitis: relationship with clinical, immunological, and functional aspects. Clin Exp Allergy. 2007;37:1528–1535.
   PubMed Web of Science ®Google Scholar
• Vandenplas O, Vinnikov D, Blanc PD, et al. Impact of rhinitis on work productivity: a systematic review. J Allergy Clin Immunol Pract. 2018;6:1274–1286 e9.
   PubMed Web of Science ®Google Scholar
• Maoua M, Maalel OE, Kacem I, et al. Quality of life and work productivity impairment of patients with allergic occupational rhinitis. Tanaffos. 2019;18:58–65.
   PubMedGoogle Scholar
• Simoens S, Laekeman G. Pharmacotherapy of allergic rhinitis: a pharmaco-economic approach. Allergy. 2009;64:85–95.
   PubMed Web of Science ®Google Scholar
• Akinbami LJ, Simon AE, Schoendorf KC. Trends in allergy prevalence among children aged 0-17 years by asthma status, United States, 2001-2013. J Asthma. 2016;53:356–362.
   PubMed Web of Science ®Google Scholar
• Cingi C, Bayar Muluk N, Scadding GK. Will every child have allergic rhinitis soon? Int J Pediatr Otorhinolaryngol. 2019;118:53–58.
   PubMed Web of Science ®Google Scholar